Francisco J. Zapatero‐Belinchón — Gladstone Institutes

Area of research

Infectious Diseases · Oncology

Research interest

Research interests include SARS-CoV-2 and COVID-19 Research, PARP inhibition in cancer therapy, COVID-19 Clinical Research Studies, and Calcium signaling and nucleotide metabolism.

Recent publications

Structure-based discovery of highly bioavailable, covalent, broad-spectrum coronavirus M <sup>Pro</sup> inhibitors with potent in vivo efficacy

Science Advances 2025cited by 12position: middledoi

The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2

eLife 2025cited by 6position: middledoi

Structure-Based Discovery of Inhibitors of the SARS-CoV-2 Nsp14 N7-Methyltransferase

Journal of Medicinal Chemistry 2023cited by 47position: middledoi

The Tetraspanin CD81 Is a Host Factor for Chikungunya Virus Replication

mBio 2022cited by 20position: middledoi

Impaired immune response mediated by prostaglandin E2 promotes severe COVID-19 disease

PLoS ONE 2021cited by 89position: middledoi

Fluvastatin mitigates SARS-CoV-2 infection in human lung cells

iScience 2021cited by 25position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Looking for a research collaborator?

Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.

Find collaborators in Infectious Diseases · Oncology →